Literature DB >> 12369879

A review of chemical agents in the pharmacotherapy of addiction.

M S Levi1, R F Borne.   

Abstract

Chemical substance abuse has tormented mankind throughout history. A number of chemical approaches have been employed in an attempt to treat chemical addiction. Unfortunately, most of these have proven unsuccessful though several chemical entities have been shown to be moderately effective. The naturally occurring alkaloid ibogaine has been reported to interrupt the cravings for alcohol, cocaine and opiates. Other alkaloids from Tabernanthe iboga, such as ibogamine and tabernanthine, provide insight into the structure activity relationship at the different receptors believed to be involved in addiction. The synthetic iboga alkaloid congener, 18-MC, also shows potential as an anti-addictive agent without the hallucinogenic effects of ibogaine. Additionally, acamprosate, BP 897, GBR12909, lofexidine and memantine have shown promising results in the treatment of addiction. All of these leads provide a start for the medicinal chemist to design anti-addictive agents, since currently no drugs are approved in the U.S. for the treatment of addictions to cocaine, methamphetamine, other stimulants or PCP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369879     DOI: 10.2174/0929867023368980

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

Review 1.  Kappa opioids as potential treatments for stimulant dependence.

Authors:  Thomas E Prisinzano; Kevin Tidgewell; Wayne W Harding
Journal:  AAPS J       Date:  2005-10-19       Impact factor: 4.009

2.  Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

Authors:  Debby Van Dam; Dorothee Abramowski; Matthias Staufenbiel; Peter Paul De Deyn
Journal:  Psychopharmacology (Berl)       Date:  2005-01-15       Impact factor: 4.530

Review 3.  Pharmacotherapy for cannabis dependence: how close are we?

Authors:  Ryan Vandrey; Margaret Haney
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  Pharmacological treatment of cannabis dependence.

Authors:  A M Weinstein; David A Gorelick
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

5.  The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters.

Authors:  Simon Bulling; Klaus Schicker; Yuan-Wei Zhang; Thomas Steinkellner; Thomas Stockner; Christian W Gruber; Stefan Boehm; Michael Freissmuth; Gary Rudnick; Harald H Sitte; Walter Sandtner
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.486

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.